Myocardial infarction as an acute physical stress Acute myocardial infarction may be viewed as an example of an acute physical disease state and as such would participate in the hormonal changes found in other medical or surgical diseases. These hormonal changes include increased plasma concentrations of ACTH (Nabarro, I969) and of cortisol (Jacobs and Nabarro, I969) . There is probably increased secretion of these hormones (Nabarro, I969) . In patients with acute burns there are high levels of urinary adrenaline and noradrenaline excretion, correlating with adrenocorticol hormone secretion (Birke et al., I958) ; other findings include glucose intolerance, a high concentration of circulating free fatty acids, and failure of response of plasma immunoreactive insulin to intravenous glucose (Allison, Hinton, and Chamberlain, I968). Such observations may explain the hyperglycaemia and pseudodiabetes found in acute burned patients (Bailey, I960) . Parallel observations in patients with a variety of physical stresses show that the plasma insulin level does not rise in spite of stress-caused hyperglycaemia (Schalch, I967) . Other changes include increased circulating free thyroxin in the plasma (Anderson, I968a) , but there is a relatively normal value for circulating growth hormone (Jacobs and Nabarro, I969) .
Many of these changes could be explained by supposing that the patient undergoes an acute stress reaction, resulting in a series of hormonal changes. A probable sequence of events may be as follows. Hypothalmic stimulation may lead to ACTH release, adrenal stimulation, and increased cortisol secretion. Sympathetic nervous system stimulation leads to increased secretion of catecholamines, which in turn results in lipid mobilization and an increased circulating free fatty acid concentration (Carlson, I968) . Catecholamine secretion may also suppress insulin secretion (Porte et al., I966) . All of these factors probably contribute to the glucose intolerance which can occur.
Myocardial infarction as an acute emotional stress It seems inevitable that at some stage the patient with acute myocardial infarction should suffer from acute emotional stress in the form of anxiety. Such anxiety may occur initially when the sudden severe chest pain is typically experienced, or later when he is brought into hospital and enters an acute coronary care unit. Anxiety may even be experienced when he is transferred from the coronary care unit to the general medical ward (Klein et al., I968 (Levi, I969) , which is similar to values found in the less severely ill patients with myocardial infarction (Valori et al., I967) . (Gazes et al., 1959) . Circulating free fatty acid concentrations are increased (Oliver, Kurien, and Greenwood, I968) and glucose utilization is impaired (Sowton, I962) . The similarity of these changes to those found in acute medical and psychological stress situations is apparent. This recognition of acute myocardial infarction as a severe generalized stress seems to be recent in origin; myocardial infarction is not included in the very many other acute stress situations discussed by Selye in I950.
The complications of acute myocardial infarction may lead to further metabolic changes. Acute left ventricular failure may cause severe dyspnoea, which would contribute to the physical and psychological stress. As expected, urinary catecholamine excretion rates in such patients are increased (Valori et Much discussion has recently centred around the possible toxic role of circulating free fatty acids in acute myocardial infarction (Oliver et al., I968; Rutenberg, Pamintuan, and Soloff, I969; Gupta et al., I969; Nelson, I970) , and dog experiments suggest that extremely high levels of free fatty acids may directly predispose to arrhythmias (Kurien, Yates, and Oliver, I969) . This is an intriguing possibility, because high circulating free fatty acid levels are susceptible to therapeutic intervention and in some non-shocked patients intravenous glucose may reduce the free fatty acid values towards normal (Gupta et al., I969 ). An adipose-tissue specific beta-blocking drug would be a useful investigative tool.
However, the actual level of circulating free fatty acid is the end result of a balance of input into the blood from adipose tissue (Cahill and Renold, I965) and uptake by the tissues. In normal subjects increased circulating free fatty acid concentrations are thought to reflect increased mobilization from adipose tissue rather than alterations in the rate of uptake by the tissues, and a similar situation is thought to occur in acute myocardial infarction (Carlson, I968; Gupta et al., I969) . Decreased uptake of free fatty acid by peripheral tissues may, however, play a role in shocked patients with poor peripheral perfusion. Fatty acid turnover studies are needed to settle this point. If increased mobilization of free fatty acid occurs, then the factors concerned may include increased catecholamine secretion (Carlson, I968; Gupta et al., I969) , alterations in insulin secretion (Allison, Chamberlain, and Hinton, I969) , and possibly increased corticosteroid production. Growth hormone is difficult to evaluate because of the extreme lability of the circulating value, but the growth hormone concentration in fasting patients with acute myocardial infarction could not be related to the free fatty acid concentration in blood (Gupta et al., I969) . The effects of simple starvation, which may be related to the degree of adiposity (Opie and Walfish, I963), must also be considered.
Examples of the problem of interpreting the meaning of the blood free fatty acid concentrations are shown in Fig. i (Henderson et al., I970) , and e normal isolated perfused heart in cc cumstances (Opie, 1970b) . It still r be shown that the blood free fatty a found in patients with acute myoc farction are toxic to the heart. In the patients shown in Fig. i Lcid levels a fall of the intracellular pH (Katz and Long, :ardial in-1925; Tennant, 1935) . This suggestion has been recently revived in much more sophistimd 2, the cated terms (Katz, I968) (Sayen et al., I958) . Perhaps a severe initial oxygen lack very rapidly breaks down some of the tissue adenosine triphosphate (ATP); its degradation product, adenosine, accumulates only fifteen seconds after coronary occlusion (Olsson, 1970) and is thought to act as a local vasodilator on the coronary circulation (Berne, I963 (Jennings, I969) , and the factors operating may include (i) unequal tissue perfusion from the collateral circulation, with severe hypoxia or anoxia in some areas; (2) a decreased rate of collateral flow; (3) continued contraction of parts of the ischaemic area; (4) the severity of the initial loss of ATP and phosphocreatine, which may result in a series of events including continuing potassium loss (Jennings, Kaltenbach, and Sommers, I965) , which could occur even in the presence of oxygen; and (5) release of catecholamines from storage sites in the myocardium, because catecholamines may cause uncoupling ofoxidative phosphorylation (Sobel et al., I966) with continued oxidative metabolism but without adequate production of ATP and phosphocreatine.
The substrate metabolism is also affected by coronary artery occlusion. There is an increased usage of glucose relative to that of free fatty acid (Owen, Thomas, and Opie, I969; Owen et al., I970) . Although free fatty acid is normally an important fuel for the heart, utilization of this substrate is impaired by oxygen lack (Scheuer, I967) . Glycolysis in the ischaemic myocardium is not subject to external control by a high concentration of circulating free fatty acids (Fig. 4) , which shows that acute arterial occlusion activates glycolysis sufficiently to overcome the normal in- Local venous blood drains the ischaemic area, and coronary sinus blood the non-ischaemic area (Owen et al., 1970) . After coronary artery ligation, arterial-local venous glucose differences increased but arterial-coronary sinus differences were unchanged. When plasma free fatty acid concentrations were increased by an infusion of Intralipid and heparin for the period between arrows, there was failure of the high plasma free fatty acid concentrations (above 4000 pmole/l. at end of infusion) to inhibit glucose uptake by the ischaemic area in contrast to inhibition in normal areas.
hibition by fatty acids (Randle et al., I963) . Factors operating to increase carbohydrate metabolism in the ischaemic myocardium may include the effects of hypoxia (Brachfeld, I969) in stimulating the transport of glucose into the heart cell, breakdown of glycogen, and increased flow through glycolysis. The cellular mechanisms responsible for these changes appear to include (i) the effects of a decreased concentration of adenosine triphosphate (ATP) , and an increased concentration of its breakdown products, such as adenosine monophosphate (AMP) and inorganic phosphate (Regen et al., I964) ; and (2) the activating effects of endogenous catecholamines (Wollenberger, Krause, and Shahab, I967; Wollenberger and Krause, I968) , which may act by production of cyclic-AMP from ATP (Sutherland, Robison, and Butcher, I968) .
Metabolic aspects of arrhythmias
In such a complex setting, with a constantly changing metabolic situation within and without the ischaemic cells, it is difficult to separate one metabolic event clearly as the sole cause of the genesis of severe arrhythmias. A cautious view at present would be that very sick patients, who are more liable to develop arrhythmias (Jewitt et al., I969; Gupta et al., I969) , are also those more likely to develop severe metabolic complications such as high values of catecholamine excretion, more severe potassium loss, higher circulating free fatty acid concentrations, and a detectable systemic acidosis. In experimental situations each of these factors may contribute to the development of severe arrhythmias.
Using a continuous bioassay technique, Ceremuzyiiski, Staszewska-Barczak, and Herbaczy:iska-Cedro (I969) showed that the incidence of ventricular arrhythmias soon after coronary artery ligation was related to the concentration of circulating catecholaniine, especially adrenaline. In dogs with complete chronic cardiac denervation the incidence of ventricular arrhythmias was much reduced . However, catecholamines may not act directly but via the potassium ion. In the normally oygenated perfused dog heart there is potassium gain after catecholamine administration, but in the ischaemic heart there is potassium loss rather than uptake (Gerlings, Miller, and Gilmore, I969) . Arrhythmias in the chronically denervated heart can be provoked by the administration of octylamine, a potassium-releasing depolarizing agent (Vanderbeek and Ebert, I970) . Another suggestion is that catecholamines might act by increasing the intracellular free fatty acid concentration, for example by stimulating the breakdown of triglycerides of the heart (Kurien and Oliver, I970) .
Potassium loss has been linked to arrhythmias in experimental myocardial ischaemia by Harris and colleagues (I954), who found a high coronary venous potassium concentration in association with ventricular fibrillation. Potassium injections also provoked ectopic activity (Harris, Toth, and Hoey, I958) . Regan and co-workers (I967) carried these observations further by showing reversal of both potassium loss and arrhythmias during antiarrhythmic therapeutic intervention such as procain amide. However, in other dog experiments, the antiarrhythmic agents lignocaine, procain amide, and propranolol were effective without reversing potassium loss (Thomas et al., I970) .
In considering the posulated toxic effects of free fatty acids (Kurien and Oliver, 1970 ) the basic biochemical differences between red and white muscle must be considered. White muscle has a lower capacity to metabolize fatty acids than does red. In the heart, the conduction system metabolically resembles white muscle, while the rest of the myocardium closely resembles red muscle (Opie, I969) . The conduction system would therefore be less able to use free fatty acids for oxidative metabolism and might be more prone to accumulate fatty acids. This difference may explain the greater susceptibility of the conduction tissue to the effects of extremely high free fatty acid concentrations.
While it is not thought that a decreased blood pH by itself causes serious arrhythmias, arterial acidosis predisposes to arrhythmias (Gerst, Fleming, and Malm, I966) , and the correction of acidosis is important in the management of cardiac arrest (Stewart, I964; Cohen and Uhley, I966) . However, after coronary artery ligation in the dog heart the fall in local venous pH in the blood draining the ischaemic zone was no different in hearts which developed ventricular fibrillation than in hearts which did not (Samson et al., I970) . Clinical evidence favours the suggestion that metabolic acidosis occurring with an arrhythmia is probably the result of circulatory failure rather than the cause of the arrhythmias (Anderson, I968b).
There is no firm evidence to implicate any single metabolic factor in the genesis of every arrhythmia, but it would be surprising if catecholamines, potassium loss, acidosis, and very high free fatty acid concentrations did not, singly or together, play a part.
End results of local metabolic response Quite at what stage the ischaemic cell irreversibly dies has not yet been settled. Probably there is no definite biochemical event which marks the transition from life to death, but rather it is the sum total of a whole sequence of changes which is responsible. Once there is a focus of non-viable cells, then the pathologist can recognize this as infarcted tissue. Although it is infarcted it is not metabolically dead.
The elegant studies of Bing and co-workers (Gudbjarnason et al., I964) 
